Old Web
English
Sign In
Acemap
>
authorDetail
>
Jean-Samuel Boudreault
Jean-Samuel Boudreault
Université de Montréal
Bortezomib
Oncology
Internal medicine
Medicine
Hematopoietic stem cell transplantation
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.
2021
Bone Marrow Transplantation
Richard LeBlanc
Imran Ahmad
Rafik Terra
Jean-Samuel Boudreault
David Ogez
Kristopher Lamore
Jean-Sébastien Delisle
Nadia M. Bambace
Lea Bernard
Sandra Cohen
Thomas Kiss
Silvy Lachance
Séverine Landais
Emilie Lemieux-Blanchard
Guy Sauvageau
Michael Sebag
Denis-Claude Roy
Jean Roy
Show All
Source
Cite
Save
Citations (0)
Canadian Retrospective Multicentric Study Comparing the Combination of Bortezomib, Cyclophosphamide and Dexamethasone (Cybord) Versus Bortezomib, Thalidomide and Dexamethasone (VTD) Versus Bortezomib and Dexamethasone (Vd) in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Hematopoietic Stem Cell Transplantation (HCT)
2018
Blood
Eric Yamga
Richard LeBlanc
Jean-Samuel Boudreault
Show All
Source
Cite
Save
Citations (0)
1